Ledger.Open graph →
SEC Form D · filed December 26, 2024

Solve Therapeutics, Inc

Offering
$75.6M
Sold
$50.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BELMONT, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Alan Y. Wen · Belmont, CAExec · DirectorCynthia Porter · New Bern, NCDirectorHyde Park Angels, Inc · DARIEN, ILExecQuantedge Capital Pte. Ltd · Singapore, U0DirectorSandalwood Securities Inc · Roseland, NJExec · DirectorJoseph Covley · Pittsford, NYExecArchana Karande · Walpole, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗